New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma
Date
2013Author
Yandim, Melis Kartal
Cincin, Zeynep Birsu
Baran, Yusuf
Kozanoglu, Ilknur
Özdoğu, Hakan
Cakmakoglu, Bedia
Metadata
Show full item recordAbstract
Propranolol, a non-selective beta-adrenergic receptor blocker, has been used for the treatment of the patients with hypertension for more than 50 years. There are several in vitro and in vivo evidences that beta-adrenergic receptor antagonists inhibit proliferation and angiogenesis and also increase apoptosis in breast, skin, and colon cancers. The aim of this study was to investigate the cytotoxic and apoptotic effects of propranolol and the genes involved in propranolol-induced apoptosis in multiple myeloma cells.
Collections
- Makale [92796]